Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing Gu

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Scientific Reports|November 11, 2014
A new non-destructive readout by using photo-recovered surface potential contrastLe Wang, Kui-juan Jin, Jun-xing Gu, et al.
ACS Applied Materials & Interfaces|December 13, 2016
Toward Switchable Photovoltaic Effect via Tailoring Mobile Oxygen Vacancies in Perovskite Oxide FilmsChen Ge, Kui-Juan Jin, Qing-Hua Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2020
Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious DiseasesF Heath Damron, Mariette Barbier, Purnima Dubey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2014
Maternal immunization: opportunities for scientific advancementRichard H Beigi, Kimberly B Fortner, Flor M Munoz, et al.
Cancer Science|January 4, 2013
Bone morphogenetic protein-9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cellsQi Li, Xing Gu, Honglei Weng, et al.
Clinical Science (London, England : 1979)|January 21, 2015
Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinomaTeng Feng, Johanna Dzieran, Xing Gu, et al.
Virology Journal|November 29, 2023
Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trialJin-Ping Zheng, Yun Ling, Liang-Shuang Jiang, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Scientific Reports|November 11, 2014
A new non-destructive readout by using photo-recovered surface potential contrastLe Wang, Kui-juan Jin, Jun-xing Gu, et al.
ACS Applied Materials & Interfaces|December 13, 2016
Toward Switchable Photovoltaic Effect via Tailoring Mobile Oxygen Vacancies in Perovskite Oxide FilmsChen Ge, Kui-Juan Jin, Qing-Hua Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2020
Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious DiseasesF Heath Damron, Mariette Barbier, Purnima Dubey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2014
Maternal immunization: opportunities for scientific advancementRichard H Beigi, Kimberly B Fortner, Flor M Munoz, et al.
Cancer Science|January 4, 2013
Bone morphogenetic protein-9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cellsQi Li, Xing Gu, Honglei Weng, et al.
Clinical Science (London, England : 1979)|January 21, 2015
Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinomaTeng Feng, Johanna Dzieran, Xing Gu, et al.
Virology Journal|November 29, 2023
Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trialJin-Ping Zheng, Yun Ling, Liang-Shuang Jiang, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.
Pageof 17